Insider · CIK 0001446125

Greenstreet Yvonne

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001446125

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-19	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+107 sh	—	—	95,802
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−129 sh	$320.01	−$41.3K	98,364
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−444 sh	$323.01	−$143K	97,278
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−265 sh	$325.67	−$86.3K	95,695
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−345 sh	$324.88	−$112K	95,960
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−368 sh	$321.82	−$118K	97,722
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−973 sh	$323.84	−$315K	96,305
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−274 sh	$320.81	−$87.9K	98,090
2026-03-04	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−135 sh	$319.03	−$43.1K	98,493
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+13.8K sh	—	—	105,427
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Price Performance Stock UnitA Award	Director, Chief Executive Officer	AAward	+111K sh	—	—	110,746
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−200 sh	$323.62	−$64.7K	105,227
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,399 sh	$327.67	−$458K	100,679
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−160 sh	$332.64	−$53.2K	98,628
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−382 sh	$324.65	−$124K	104,845
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−399 sh	$331.93	−$132K	98,788
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−346 sh	$330.85	−$114K	99,187
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−722 sh	$329.71	−$238K	99,533
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+30.4K sh	—	—	30,425
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−424 sh	$328.71	−$139K	100,255
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,098 sh	$325.63	−$358K	103,747
2026-03-02	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,669 sh	$326.81	−$545K	102,078
2026-02-27	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,921 sh	—	—	0
2026-02-27	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,921 sh	—	—	91,583
2026-02-13	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−6,958 sh	$310.08	−$2.16M	85,662
2026-02-12	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+14.2K sh	—	—	92,620
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−301 sh	$363.55	−$109K	82,918
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,259 sh	$364.83	−$459K	81,659
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−537 sh	$359.14	−$193K	85,287
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−464 sh	$362.38	−$168K	83,219
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−980 sh	$360.22	−$353K	84,307
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−1,395 sh	$365.56	−$510K	80,264
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−624 sh	$361.45	−$226K	83,683
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−118 sh	$375.65	−$44.3K	78,505
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−21 sh	$372.46	−$7,821.66	78,711
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−94 sh	$377.82	−$35.5K	78,411
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−607 sh	$357.17	−$217K	86,602
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−118 sh	$370.87	−$43.8K	78,732
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−263 sh	$356.09	−$93.7K	87,209
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−261 sh	$367.40	−$95.9K	79,687
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−584 sh	$368.62	−$215K	79,103
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−778 sh	$358.18	−$279K	85,824
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−253 sh	$369.48	−$93.5K	78,850
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−269 sh	$355.16	−$95.5K	87,472
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−247 sh	$353.95	−$87.4K	87,741
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−88 sh	$374.44	−$33K	78,623
2026-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−316 sh	$366.41	−$116K	79,948
2026-01-11	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+19K sh	—	—	87,988
2025-11-26	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−659 sh	—	—	28,141
2025-11-26	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−847 sh	—	—	0

Greenstreet Yvonne

Insider transactions

Recent filings

Companies

Address